Simcere Zaiming Announces First Patient Dosed in the US in a Phase 1 Trial of Trispecific Antibody SIM0500 in Patients with Relapsed/Refractory Multiple Myeloma
Share Facebook Twitter LinkedIn Pinterest Email THE HERD WITH COLIN COWHERD Trending MLB NFL UFL NTT INDYCAR SERIES NASCAR LIV NBA PGA NCAABK NCAAFB
